These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 16147848

  • 21. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels.
    Madazli R, Aydin S, Uludag S, Vildan O, Tolun N.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):797-802. PubMed ID: 12911439
    [Abstract] [Full Text] [Related]

  • 22. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
    Visser W, Beckmann I, Knook MA, Wallenburg HC.
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
    [Abstract] [Full Text] [Related]

  • 23. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
    Molvarec A, Jermendy A, Nagy B, Kovács M, Várkonyi T, Hupuczi P, Prohászka Z, Rigó J.
    Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A prospective study of early-pregnancy plasma malondialdehyde concentration and risk of preeclampsia.
    Rudra CB, Qiu C, David RM, Bralley JA, Walsh SW, Williams MA.
    Clin Biochem; 2006 Jul; 39(7):722-6. PubMed ID: 16603146
    [Abstract] [Full Text] [Related]

  • 26. TNF-receptor levels in preeclampsia--results of a longitudinal study in high-risk women.
    Schipper EJ, Bolte AC, Schalkwijk CG, Van Geijn HP, Dekker GA.
    J Matern Fetal Neonatal Med; 2005 Nov; 18(5):283-7. PubMed ID: 16390786
    [Abstract] [Full Text] [Related]

  • 27. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
    Powers RW, Roberts JM, Cooper KM, Gallaher MJ, Frank MP, Harger GF, Ness RB.
    Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
    [Abstract] [Full Text] [Related]

  • 28. Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women.
    Sanchez SE, Zhang C, Williams MA, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A.
    J Reprod Immunol; 2000 May; 47(1):49-63. PubMed ID: 10779590
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women.
    Okazaki S, Sekizawa A, Purwosunu Y, Farina A, Wibowo N, Okai T.
    Obstet Gynecol; 2007 Nov; 110(5):1130-6. PubMed ID: 17978129
    [Abstract] [Full Text] [Related]

  • 31. Intimate partner violence (IPV) and preeclampsia among Peruvian women.
    Sanchez SE, Qiu C, Perales MT, Lam N, Garcia P, Williams MA.
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):50-5. PubMed ID: 17600610
    [Abstract] [Full Text] [Related]

  • 32. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
    Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minawi AM.
    J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
    [Abstract] [Full Text] [Related]

  • 33. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women.
    Williams MA, Woelk GB, King IB, Jenkins L, Mahomed K.
    Am J Hypertens; 2003 Aug; 16(8):665-72. PubMed ID: 12878373
    [Abstract] [Full Text] [Related]

  • 34. Risk of preeclampsia in relation to maternal history of migraine headaches.
    Adeney KL, Williams MA, Miller RS, Frederick IO, Sorensen TK, Luthy DA.
    J Matern Fetal Neonatal Med; 2005 Sep; 18(3):167-72. PubMed ID: 16272039
    [Abstract] [Full Text] [Related]

  • 35. Erythrocyte omega-3 and omega-6 polyunsaturated fatty acids and preeclampsia risk in Peruvian women.
    Qiu C, Sanchez SE, Larrabure G, David R, Bralley JA, Williams MA.
    Arch Gynecol Obstet; 2006 May; 274(2):97-103. PubMed ID: 16520922
    [Abstract] [Full Text] [Related]

  • 36. Dietary fiber intake in early pregnancy and risk of subsequent preeclampsia.
    Qiu C, Coughlin KB, Frederick IO, Sorensen TK, Williams MA.
    Am J Hypertens; 2008 Aug; 21(8):903-9. PubMed ID: 18636070
    [Abstract] [Full Text] [Related]

  • 37. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
    Lin Y, Kikuchi S, Tamakoshi A, Obata Y, Yagyu K, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y, Ishibashi T, JACC Study Group.
    Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
    [Abstract] [Full Text] [Related]

  • 38. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y, Kikuchi S, Obata Y, Yagyu K, Tokyo Research Group on Prevention of Gastric Cancer.
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [Abstract] [Full Text] [Related]

  • 39. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia.
    Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA.
    Am J Epidemiol; 1999 Feb 15; 149(4):323-9. PubMed ID: 10025474
    [Abstract] [Full Text] [Related]

  • 40. Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia.
    Vadachkoria S, Sanchez SE, Qiu C, Muy-Rivera M, Malinow MR, Williams MA.
    Gynecol Obstet Invest; 2004 Feb 15; 58(3):133-9. PubMed ID: 15205565
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.